¿Cuál es el futuro de las analíticas aplicadas a la atención médica en Latinoamérica?
Únanse para una conversación entre Lee Ullmann (@MITSloanLatAm), director de la Oficina para América Latina de MIT Sloan, Juan Velásquez (@juandvelasquez), profesor de la Universidad de Chile, y Andrea Obaid (@AndreaObaid), periodista, autora y nuestra presentadora. Platicaremos sobre el futuro de la atención médica en Latinoamérica.
La plática por Twitter tendrá lugar el 15 de mayo desde las 13:30 hasta las 14:30 CLT (1:30 – 2:30 PM ET).
¿Cómo pueden participar? ¡Es sencillo! Si tienen una pregunta, respuesta o comentario, simplemente incluyan #MITHealthUChile en sus Tweets.
La conversación en Twitter es un precursor de la conferencia “Strategy Analytics: Changing the Future of Healthcare” (“Estadísticas Estratégicas: Cambiando el Futuro de la Atención Médica”), organizada por la escuela de negocios MIT Sloan con participación de la Universidad de Chile. Tendrá lugar el 25 de mayo en Santiago, Chile. La conferencia reunirá a investigadores y líderes del rubro de la salud y de instituciones gubernamentales, y más de una docena de presentadores discutirán formas de desplegar información y estadísticas para impulsar la innovación en la industria.
En promoción de las ideas de la conferencia, tendremos una conversación en Twitter sobre el futuro de la atención médica de Latinoamérica, así como otras ideas de interés a tratarse en la agenda.
MIT Sloan Prof. Retsef Levi
From NEJM Catalyst
Thanks to the revolution in biologic therapy, the annual number of intravenous infusions at the Massachusetts General Hospital (MGH) rheumatology clinic’s small (two-chair) infusion center increased from 1,247 to 1,856 between 2009 and 2014. Related billings skyrocketed from nearly $16 million to more than $40 million. To understand this major shift, one must pause briefly to appreciate the medical history that led to it and then to examine how MGH is redesigning its care processes to bring these novel therapies to patients. Central to the plan is a collaboration with academic partners at the MIT Sloan School of Management.
The Medical Backstory
In 1980, a rheumatoid arthritis (RA) patient at the MGH rheumatology clinic would have received a weekly in-clinic infusion of gold salts and, occasionally, undergone laboratory monitoring.
MIT Sloan Assoc. Prof. Joseph Doyle
From The Hill
Most discussions about the state of the U.S. healthcare system start with the problem of unsustainable cost growth. One reason costs have been rising is that we (as a society and as consumers) find enormous value in health improvements and are willing to pay for them. The real question is how to identify value vs. waste in healthcare so we can increase efficiency to bring costs down.
Over the years, we’ve seen many attempts to revamp the healthcare system, but they have been insufficient to be transformative. A good example is the HMO model in the 80s and 90s, which was notorious for restricting access to care. During the healthcare reform debate, voters balked at the U.S. government coming anywhere near restraining spending on healthcare. Read More
MIT Sloan Senior Lecturer Robert Pozen
Underfunded/unfunded retiree healthcare is a topic that gets little attention in the finance media. All the attention has been paid to pension funds, but retiree healthcare is in worse shape. For example, if a pension fund is only 70 percent funded, it is considered extremely underfunded. And yet retiree healthcare plans are on average only four percent funded.
The question is, why?
MIT Sloan Professor of Management, Emerita Lotte Bailyn
How do today’s Baby Boomers—many of whom are still healthy and active—view their retirement? The traditional image of these so-called Golden Years involves leisure and freedom: mornings on the golf course, afternoons puttering in the garden, perhaps with some globetrotting and grandchildren thrown in for good measure. (Of course this option is only open to those who through pension plans or savings have the means for it.
In recent years, a second image of retirement, known as “aging in work,” has emerged. This model, borne in response to the economic need to protect Social Security and retain experienced workers’ knowledge, keeps retirement-age employees working in part-time or contract positions. It’s sold as win-win: Companies and the country benefit financially, but employees benefit, too, because it keeps their brains active and their social networks strong. The assumption is that continuing to work, though under better, more flexible conditions, is what makes people happy. The mainstream media back the model. Why Working Longer Is Good For Your Health and Get back to work! Working past “retirement age” is beneficial are just a few recent headlines.